Lifecore Biomedical Inc. (LFCR)
NASDAQ: LFCR
· Real-Time Price · USD
7.83
0.12 (1.56%)
At close: Sep 04, 2025, 1:44 PM
1.56% (1D)
| Bid | 7.81 |
| Market Cap | 292.73M |
| Revenue (ttm) | 128.87M |
| Net Income (ttm) | -38.72M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -6.16 |
| Forward PE | -10.36 |
| Analyst | Hold |
| Ask | 7.86 |
| Volume | 247,663 |
| Avg. Volume (20D) | 148,551 |
| Open | 7.62 |
| Previous Close | 7.71 |
| Day's Range | 7.47 - 8.69 |
| 52-Week Range | 4.33 - 8.85 |
| Beta | 0.65 |
About LFCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LFCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LFCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Lifecore Biomedical Inc. is scheduled to release its earnings on
Oct 3, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-22.32%
Lifecore Biomedical shares are trading lower after...
Unlock content with
Pro Subscription
11 months ago
+14.23%
Lifecore Biomedical shares are trading higher after the company reported better-than-expected Q1 revenue results.
3 weeks ago · seekingalpha.com
Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call TranscriptUniversal Electronics Inc. (UEIC) Q4 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Paul Josephs - President, CEO & Director Ryan D. Lake - EVP & CFO Conference Call Part...
